5-aminoisoquinolinone has been researched along with Respiratory Distress Syndrome in 2 studies
5-aminoisoquinolinone: structure in first source
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Genovese, T | 1 |
| Mazzon, E | 2 |
| Di Paola, R | 1 |
| Muià, C | 1 |
| Threadgill, MD | 1 |
| Caputi, AP | 2 |
| Thiemermann, C | 2 |
| Cuzzocrea, S | 2 |
| McDonald, MC | 1 |
| Dugo, L | 1 |
| Serraino, I | 1 |
| Threadgill, M | 1 |
2 other studies available for 5-aminoisoquinolinone and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and the development of bleomycin-induced lung injury.
Topics: Animals; Benzamides; Bleomycin; Enzyme Inhibitors; Isoquinolines; Male; Mice; Poly(ADP-ribose) Polym | 2005 |
Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury.
Topics: Animals; Cell Survival; Cytokines; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; | 2002 |